Importantly, treatment with MK2206, a specific inhibitor of the AKT signaling pathway, thoroughly blocked L1‐enhanced tumor invasion and tube formation in glioma cells (Fig. 7B,C). The gene discussed is AKT1; the disease is central nervous system cancer.